Kyverna Therapeutics, Inc. - KYTX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$447.5M
QoQ value delta ($000)
+$145.4M (+48.1%)
Implied price effect (QoQ)
+36.73%
Shares
Total shares
37,933,229
QoQ shares delta
+2,912,580 (+8.32%)
Total shares held by funds (by quarter)

Market chart (KYTX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 121 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
CAXTON CORP 110,009 12,347 5.94%
GordonMD Global Investments LP 37,821 4,244,818 18.3%
GILEAD SCIENCES, INC. 36,763 4,126,119 2.23%
BlackRock, Inc. 27,931 3,134,807 0.0%
Bain Capital Life Sciences Investors, LLC 25,705 2,885,000 1.53%
AIGH Capital Management LLC 24,910 2,795,797 1.57%
DEERFIELD MANAGEMENT COMPANY, L.P. 17,820 2,000,000 0.19%
VANGUARD CAPITAL MANAGEMENT LLC 16,906 1,897,451 0.0%
PRICE T ROWE ASSOCIATES INC /MD/ 10,569 1,186,023 0.0%
GEODE CAPITAL MANAGEMENT, LLC 9,352 1,049,430 0.0%
Insight Holdings Group, LLC 8,812 989,054 0.67%
MORGAN STANLEY 8,752 982,307 0.0%
STATE STREET CORP 8,751 982,233 0.0%
Propel Bio Management, LLC 7,869 883,198 4.12%
Woodline Partners LP 7,531 845,325 0.02%
MILLENNIUM MANAGEMENT LLC 5,700 639,780 0.0%
MBB PUBLIC MARKETS I LLC 5,474 614,477 0.59%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,455 500,000 0.01%
D. E. Shaw & Co., Inc. 4,181 469,346 0.0%
WELLS FARGO & COMPANY/MN 3,323 373,009 0.0%
UBS Group AG 3,257 365,574 0.0%
GOLDMAN SACHS GROUP INC 2,986 335,230 0.0%
RENAISSANCE TECHNOLOGIES LLC 2,975 333,899 0.0%
CITADEL ADVISORS LLC 2,868 321,927 0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2,848 319,666 0.0%